Table 2 Most significant KEGG pathways with altered expression in terms of disease

CCGs

 Oxidative phosphorylation

22

3.18E−19

2.62E−14

 ^*Parkinson’s disease

21

2.63E−17

1.81E−12

 Alzheimer’s disease

22

4.60E−17

3.75E−12

 *Non-alcoholic fatty liver disease (NAFLD)

21

1.12E−14

6.41E−10

 Huntington’s disease

19

2.72E−14

1.05E−09

 Metabolic pathways

41

7.24E−12

3.04E−06

ICGs

 Vitamin digestion and absorption

8

1.22E−7

1.52E−04

 Fat digestion and absorption

41

3.57E−4

0.4450

 Protein digestion and absorption

6

8.80E−4

1.0931

 Metabolic pathways

8

1.63E−3

1.9248

 Chemical carcinogenesis

7

4.53E−3

5.4888